Introgen Therapeutics' Series A Round

Introgen Therapeutics raised a round of funding on January 01, 1996.

Introgen's objective is to be the leader in the development of molecular therapies and other products for the treatment of cancer and other diseases that, like cancer, result from cellular dysfunction…

Articles about Introgen Therapeutics' Series A Round: